Science and Technology,
Compassion and Care.
Science and Technology,
Compassion and Care.
Who we are
Founded in 2015 by neuroscientists and technologists Dr. David Eagleman and Dr. Yael Katz, BrainCheck helps reduce the human and economic toll of cognitive impairment and dementia through its interactive cognitive assessment and cognitive care planning technology.
Hundreds of hospitals and clinical practices use the BrainCheck platform, to help thousands of patients live better and safer lives at home, to decrease caregiver frustration, and to save health systems trillions of dollars.
We envision a world where everyone has access to insight about their cognitive function. Where cognitive changes are detected early, and where diseases like Alzheimer’s and other dementias are preventable and treatable. A world without cognitive impairment.
Chief Executive Officer
Kim Rodriguez has 25 years of global healthcare and medical device industry experience, spanning multiple therapeutic areas—including neurology, cardiology, and women’s health. Most recently, as a Venture Partner at S3 Ventures, she supported the firm’s healthcare investments. Earlier, she served as CEO & Co-Founder of Acessa Health—a venture-backed startup providing a minimally-invasive, uterine-sparing fibroid treatment for women. Under her leadership, the company raised $30M, launched a new product, obtained broad insurance coverage, and was acquired by Hologic for over $120M in upfront and expected follow-on payments. Previously, Kim was CEO at Halt Medical and led the largest business unit, Vascular Intervention, at Spectranetics (acq. by Royal Philips for $2.2B). She has held senior leadership positions at Johnson & Johnson, Blockade Medical (acq. by Balt International), Concentric Medical (acq. by Stryker Neurovascular), Guidant Corporation (acq. by Abbott Vascular), and Microvena (acq. by ev3). Kim received her Executive MBA at the University of Southern California Marshall School of Business and BS in Management from Pepperdine University.
David Eagleman, PhD
Chief Science Officer & Co-Founder
Dr. David Eagleman is a visionary leader in the neuroscience field. He currently teaches at Stanford University and heads the Center for Science and Law. In addition to receiving numerous awards for his academic research and work, David is a New York Times best-selling author, a TED speaker, and the creator and host of the Emmy-nominated PBS series, The Brain.
Reza Hosseini Ghomi, MD
Chief Medical Officer
Dr. Reza Hosseini Ghomi is a practicing neuropsychiatrist, focused on neurodegenerative disorders. In addition to serving as Chief Medical Officer at BrainCheck, he is faculty of the University of Washington department of neurology and Institute for Neuroengineering. Reza received his MD from the University of Massachusetts Medical School, has post-graduate training in psychiatry and neurology, and holds an MSE in biomedical and electrical engineering from Johns Hopkins University.
Chief Revenue Officer
Matt is an accomplished leader with 15 years of experience driving top line revenue for medical device and digital health solutions across the provider and payer landscape. His collaborative approach to transforming sales processes to align with a strategic vision has proven to dramatically fuel growth and business development initiatives.
Chief Product Officer
Nathaniel Zastrow brings product management experience across a broad set of industries including healthcare, mobile technology, data gathering, enterprise software, and infrastructure. He joined BrainCheck from Signify Health, the market leader in home Health Risk Assessments for Medicare Advantage plans. Nathaniel grew Signify Health's In-Home Evaluations business unit from 300,000 assessments per year to more than 2,500,000 assessments per year over the course of his tenure at Signify Health. He holds a Bachelor of Arts degree in Government from the University of Texas at Austin and a Masters of Business Administration from the Cox School of Business at Southern Methodist University.
Vice President of Engineering
Vice President of Marketing
Chelsea Dugan is an accomplished global marketing leader with extensive experience in the medical technology industry, spanning multiple clinical areas including radiology, radiation oncology, surgery and dermatology. She joined BrainCheck from iCAD, Inc., the market leader in artificial intelligence (AI) for breast cancer detection, density assessment, and risk evaluation. Under her leadership, iCAD’s brand health experienced significant improvement year-over-year, attracting key strategic partners including Google Health and driving worldwide adoption. She holds a Bachelor of Arts degree in Journalism from the University of Massachusetts Amherst and a Masters of Business Administration from the F.W. Olin Graduate School of Business at Babson College.